Researchers from Tokyo Metropolitan University have created a new molecule which carries DNA into biological cells, to treat or vaccinate against illnesses. Many existing options rely on molecules ...

A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...

To mark the launch, Volta Labs and Watchmaker Genomics will host a joint in suite presentation at AGBT 2026 on February 24 at 8:30 a.m. in the Fulton Suite, where attendees can learn more about the ...

Getting DNA into a living cell sounds simple, until you remember the cell’s outer membrane acts like a guarded wall. DNA ...

The U.S. Court of Appeals for the Federal Circuit (CAFC) in a precedential decision on Friday reversed a district court’s ...

Researchers from Tokyo Metropolitan University have created a new molecule which carries DNA into biological cells, to treat or vaccinate against illnesses.

New workflow validated on Dynamic Devices Lynx® delivers scalable plasmid DNA extraction from Midi to Maxi-prep volumes ...

Collaborations with top automation, sequencing, & technology partners highlight Omega's commitment to advancing ...

Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing ...

The rise of gene editing forces regulators to confront a difficult question: How to protect fair play in the age of genomic medicine.

A new DNA immunotherapy, Elenagen, doubled survival (13 to 25+ months) for tough ovarian cancers when added to chemotherapy, with fewer side effects.

Based on these challenges, a comprehensive reassessment of how AI should be deployed in electrocatalysis has become urgently needed. Addressing this need, a review published (DOI: 10.1016/j.esci.2025.